Fig. 6From: GITR ligand fusion protein agonist enhances the tumor antigen–specific CD8 T-cell response and leads to long-lasting memoryGeneration of E7-specific GITR expression in TC-1 tumor‒bearing mice vaccinated with 10 μg of E7 SLP in CpG (Addavax) in the base of the tail. E7-specific CD8 T cells were evaluated in (a) spleens and (b) tumors. GITR levels were evaluated on E7 DEX+ cells and E7 DEX‒ CD8 T cells in (c) spleen and (d) tumorBack to article page